Patricia McCrink’s 30+ years in oncology nursing are distinguished by sustained bedside presence, emotional support, and ...

New Hodgkin lymphoma recommendations emphasise PET guided and risk adapted treatment strategies across disease stages.

Hodgkin’s lymphoma is a type of cancer that starts growing in the white blood cells of the immune system. There are two different types and five subtypes, each with different characteristics.

Hodgkin lymphoma (HL) is a treatable cancer with an incidence peak in adolescent and young adult years. Treatment strategies have been developed to balance the intensity of therapy needed to maintain ...

Improved biologic insight has led to the development of novel agents for non-Hodgkin lymphoma, which are now available in routine care. For patients with newly diagnosed diffuse large B-cell lymphoma, ...

Hodgkin’s lymphoma is definitively diagnosed by the presence of Reed-Sternberg cells, whereas Non-Hodgkin’s lymphoma involves a wider range of lymphoid variations and is classified based on cell ...

Hodgkin’s lymphoma is a type of cancer that affects the lymphatic system, including the lymph nodes. The cancer typically spreads from one lymph node to a neighboring one. People with Hodgkin’s ...

Nodular sclerosis disease often involves mediastinal nodes and shows fibrous bands partitioning lymphoid tissue into nodules around Reed–Sternberg cells. Definitive workup requires excisional lymph ...

The first prediction model to be developed for early-stage classic Hodgkin lymphoma, focusing on just four key risk factors that are assessed via an easy-to-use online risk calculator, provides ...

Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity. A Stanford Medicine-led, ...